HABP4

Across TCGA pan-cancer cohorts, HABP4 mass-spec protein is linked to patient survival in 5 of 34 cancer types, making it a survival-associated HABP4 data layer compared with 22 for mass-spec protein and 3 for mutation status.

The strongest signal is observed in clear cell renal cell carcinoma (CCRCC), where higher HABP4 mass-spec protein is associated with better overall survival. In most high-consensus cancer types, elevated HABP4 expression acts as an unfavorable survival marker, although some lineages such as CCRCC and HNSC show a favorable association.

CCRCC, LSCC, and HNSC are the cancer types where HABP4 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CCRCC	OS	Median	All	0.942	0.726	<.001	40	view →
LSCC	DFS	Median	II,III,IV	0.633	0.892	.006	20	view →
HNSC	OS	Quartile	III,IV	0.953	0.784	.005	8	view →
LUAD	DFS	Median	All	0.727	0.497	.013	6	view →
PDAC	OS	Tertile	IV	0.916	0.231	.024	3	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

HABP4–CCRCC (OS)

Open the CCRCC breakdown →